Effectiveness and Safety of Glecaprevir/Pibrentasvir Combination Therapy in Patients Diagnosed with Chronic Hepatitis C

The GLE/PIB combination is an effective and safe treatment option in the treatment of HCV infection. Due to the high EVR rates, more comprehensive studies need to be conducted to keep the duration of GLE/PIB treatment shorter in some patient groups in patients diagnosed with CHC.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Practice and Research
Published
2025-01-01
DOI
https://doi.org/10.14744/cpr.2025.33623
Primary Topic
Hepatitis C virus research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness and Safety of Glecaprevir/Pibrentasvir Combination Therapy in Patients Diagnosed with Chronic Hepatitis C

Kaan Karabulut
Journal of Clinical Practice and Research
Hepatitis C virus research
article

Effectiveness and Safety of Glecaprevir/Pibrentasvir Combination Therapy in Patients Diagnosed with Chronic Hepatitis C

Kaan Karabulut
article en

Abstract

The GLE/PIB combination is an effective and safe treatment option in the treatment of HCV infection. Due to the high EVR rates, more comprehensive studies need to be conducted to keep the duration of GLE/PIB treatment shorter in some patient groups in patients diagnosed with CHC.

Journal of Clinical Practice and ResearchVol. 47(3)
Erciyes University (TR)
Good health and well-being
Openalex Percentile: Top 80%
Hepatitis C virus research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effectiveness and Safety of Glecaprevir/Pibrentasvir Combination Therapy in Patients Diagnosed with Chronic Hepatitis C — Kaan Karabulut · Journal of Clinical Practice and Research (2025) | TGRS Research Map | TGRS